Skip to content

To Study The Effect Of Nyagrodhadi Lepa And Manjisthadi Lepa In The Management Of Ankle Sprain And Wrist Sprain

A Clinico-Comparative Study Of Nyagrodhadi Lepa And Manjisthadi Lepa In The Management Of Rujakarmarmakshata Of Gulpha Sandhi And Manibandha Sandhi(Ankle Sprain And Wrist Sprain) - No

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034173
Enrollment
40
Registered
2021-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Manjisthadi Lepa: Manjisthadi Lepa Application On Affected Part Twice a Day For 7 Days Total Dose For 1 Patient-1920gm Total Dose For 20 Patients-38400gm Control Intervention1: Nyagrodh

Sponsors

Government Akhandanand Ayurveda College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients With Classical Signs And Symptoms Of Rujakarmarmakshata(Sprain)like Ruja(Pain)Shotha(Swelling)Snayustabdhata(Stiffness)Alpakaryakshamtva(Difficulty In Movement)Tenderness Or Among Of Them Minimum Two Of These Sign And Symptoms If Present Will Be Included First And Up To Second Grade Of Sprain

Exclusion criteria

Exclusion criteria: Age Below 18 Years And Above 60 Years Third Grade Of Sprain Localised Defects Like Pathological Fracture Open Wound Acquired Anomalies Like Osteomyelitis Rheumatoid Arthritis And Coagulopathy Like Hemophilia Fractures With Complications Like Injury To Blood Vessels Or Nerves

Design outcomes

Primary

MeasureTime frame
Effect Of Both Therapies On Sign And Symptoms Of Rujakar Marmakshata Of Gulpha Sandhi And Manibandha Sandhi(Ankle Sprain And Wrist Sprain) Sign And Symptoms 1 Ruja Pain 2 Shotha Swelling 3 Snayustabdhta Stiffness 4 Alpakaryakshamatva Difficulty In Movement 5 TendernessTimepoint: 7days

Secondary

MeasureTime frame
To Stop Recurrence And Improve The Quality Of LifeTimepoint: 21 Days

Countries

India

Contacts

Public ContactDr Harshit Shah

Government Akhandanand Ayurved College And Hospital

akhandanandprincipal@gmail.com9824068760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026